Litcius/Paper detail

Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia

Nicholas A Keks, Judy Hope, Darren Schwartz, Harold McLennan, David Copolov, Graham Meadows

2020CNS Drugs70 citationsDOI

Topics & Concepts

Partial agonistAkathisiaAripiprazoleDopamine receptor D3PsychologyPharmacologyDopamine receptor D2Tardive dyskinesiaExtrapyramidal symptomsTolerabilityMedicineAdverse effectDopamineAntipsychoticInternal medicineAgonistSchizophrenia (object-oriented programming)PsychiatryReceptorSchizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia | Litcius